Shahram Salek-Ardakani
Nessuna posizione attualmente
Profilo
Shahram Salek-Ardakani held the position of Senior Director-Cancer Immunology at Pfizer Inc. He also worked as an Associate Professor at the University of Florida College of Medicine.
Currently, he is serving as the Chief Scientific Officer at Janux Therapeutics, Inc. from 2021 to 2023.
Precedenti posizioni note di Shahram Salek-Ardakani
| Società | Posizione | Fine |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/11/2023 |
| University of Florida College of Medicine | Corporate Officer/Principal | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
8
Relazioni di 1° grado
3
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| JANUX THERAPEUTICS, INC. | Health Technology |
- Borsa valori
- Insiders
- Shahram Salek-Ardakani
